Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | PTGDR2 | Q9Y5Y4 | 6/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.40 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL237888 | 0.92 | PSMB5 (0.50) | PTGDR2METAP2PSMB5ALDH1A1 | |
| SCHEMBL235802 | 0.90 | PPARA (0.48) | PSMB5ALDH1A1 | |
| SCHEMBL237036 | 0.89 | PPARA (0.50) | ALDH1A1 | |
| SCHEMBL237711 | 0.89 | PPARA (0.50) | ALDH1A1 | |
| SCHEMBL27809611 | 0.88 | PTGDR2 (0.50) | PTGDR2BACE1NPC1ALDH1A1RAB9A | |
| SCHEMBL238575 | 0.84 | SLC13A5 (0.48) | ALDH1A1 | |
| SCHEMBL21462963 | 0.79 | GABRA1 (0.40) | GABRA1GABRB2CNR1CNR2PTGDR2 | |
| SCHEMBL5192971 | 0.78 | GAA (0.49) | CNR1CNR2 | |
| SCHEMBL9509918 | 0.77 | METAP2 (0.53) | CNR1CNR2METAP2PTPN1 | |
| SCHEMBL122492 | 0.76 | PTGDR2 (0.65) | PTGDR2BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114650915-B | Layer structure with modified structure and production thereof | 科思创德国股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-117203063-A | Method for locally coloring plastic parts using solid dyes in a color carrier layer | 科思创德国股份有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-111542565-B | Plastic film with reduced UV activity | 科思创德国股份有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-114746488-A | Films with special properties | 科思创知识产权两合公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-114650915-A | Layer structure with modified structure and production thereof | 科思创知识产权两合公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-108778766-B | Method for partially dyeing plastic parts | 科思创德国股份有限公司 | 2021-12-31 | — | — | CN | disclosed |
| US-20210371609-A1 | PLASTIC FILMS WITH REDUCED UV ACTIVITY | COVESTRO LLC | 2021-12-02 | — | — | US | disclosed |
| EP-3707198-B1 | PLASTIC FILMS WITH REDUCED UV ACTIVITY | COVESTRO DEUTSCHLAND AG (DE) | 2021-10-27 | — | — | EP | disclosed |
| CN-113242795-A | Plastic film with high opacity and low transparency for identification documents with transparent window | 科思创知识产权两合公司 | 2021-08-10 | — | — | CN | disclosed |
| CN-113056369-A | Method for producing a laminate comprising electronic components and/or functional units | 科思创知识产权两合公司 | 2021-06-29 | — | — | CN | disclosed |
| US-20110206568-A1 | PROCESS FOR THE PREPARATION OF DIARYL CARBONATES OR ARYLALKYL CARBONATES FROM DIALKYL CARBONATES | BAYER MATERIALSCIENCE AG (DE) | 2011-08-25 | — | — | US | disclosed |
| US-8003817-B2 | Process for the preparation of diaryl carbonates or arylalkyl carbonates from dialkyl carbonates | BAYER MATERIALSCIENCE AG (DE) | 2011-08-23 | — | — | US | disclosed |
| US-7814626-B2 | Process for the preparation of polycarbonate by the melt transesterification process | BAYER MATERIALSCIENCE AG (DE) | 2010-10-19 | — | — | US | disclosed |
| US-20090076293-A1 | PROCESSES FOR PREPARING DIARYL AND/OR ALKYLARYL CARBONATES FROM DIALKYL CARBONATES | BAYER MATERIALSCIENCE AG (DE) | 2009-03-19 | — | — | US | disclosed |
| US-20080319156-A1 | Process For The Preparation Of Polycarbonate By The Melt Transesterification Process | BAYER MATERIALSCIENCE AG (DE) | 2008-12-25 | — | — | US | disclosed |
| US-20080293960-A1 | Process For The Preparation Of Diaryl Carbonates Or Arylalkyl Carbonates From Dialkyl Carbonates | BAYER MATERIALSCIENCE AG (DE) | 2008-11-27 | — | — | US | disclosed |
| US-7250483-B2 | Inhibition of catalytically active impurities in polycarbonate by the melt transesterification process | BAYER MATERIALSCIENCE AG (DE) | 2007-07-31 | — | — | US | disclosed |
| US-7091302-B2 | Process for the preparation of polycarbonate | BAYER MATERIALSCIENCE AG (DE) | 2006-08-15 | — | — | US | disclosed |
| US-20060004178-A1 | Inhibition of catalytically active impurities in polycarbonate by the melt transesterification process | COVESTRO DEUTSCHLAND AG (DE) | 2006-01-05 | — | — | US | disclosed |
| US-20050239995-A1 | Process for the preparation of polycarbonate | BAYER MATERIALSCIENCE AG | 2005-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293960-A1 | Process For The Preparation Of Diaryl Carbonates Or Arylalkyl Carbonates From Dialkyl Carbonates | HDHD5, ALKBH3, AHR | GABRA1 4379/4885GABRB2 4342/4885CNR1 1022/4885 |
| US-20090076293-A1 | PROCESSES FOR PREPARING DIARYL AND/OR ALKYLARYL CARBONATES FROM DIALKYL CARBONATES | DHCR7, ADH1C, AKR1C4 | GABRA1 3582/4885GABRB2 3216/4885CNR1 1181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.